最后审阅: 17 九月 2021
最后更新: 06 七月 2020

小结

定义

病史和体格检查

关键诊断因素

  • 一氧化碳暴露的风险
  • 头痛
  • 恶心
  • 呕吐
  • 眩晕
  • 意识障碍
  • 头晕
  • 呼吸困难
  • 疼痛
  • 睡眠改变
  • 情绪不稳定

其他诊断因素

  • 延迟性神经精神病特征
  • 其他严重神经系统症状
  • 局灶性神经系统异常

危险因素

  • 未完全燃烧的含碳燃料
  • 二氯甲烷

诊断性检查

首要检查

  • 血气分析
  • 12 导联心电图
  • 血压
  • 心脏监测
  • 葡萄糖
  • 全血细胞计数
  • 尿素和电解质
  • 肌钙蛋白水平
  • 肌酸激酶

需考虑的检查

  • 简明精神状态检查
  • 头颅 CT
  • 磁共振波谱
  • 胸部 X 线检查
  • 肝功能检测

治疗流程

急症处理

撰稿人

专家顾问

Alexander Alexiou, MB, BS, BSc, DCH, FRCEM, Dip IMC RCSEd

Flight Doctor

Greater Sydney Area Helicopter Emergency Medical Service

Sydney

Australia

利益声明

AA declares that he has no competing interests.

鸣谢

BMJ Best Practice would like to gratefully acknowledge the previous team of expert contributors, whose work is retained in parts of the content:

Jason J Rose, MD, MBA

Assistant Professor of Medicine and Biomedical Engineering

University of Pittsburgh

Pittsburgh

PA

Disclosures: JJR is a co-inventor on patent applications for the use of heme-based molecules as antidotes for CO poisoning. JJR is a shareholder, officer, and director of Globin Solutions, Inc. Globin Solutions, Inc. has an exclusive license to this technology. Globin Solutions, Inc. had an option agreement to technology directed at using hydroxycobalamin for CO poisoning from Virginia Commonwealth University in the last 12 months. JJR is an author of publications cited within this topic.

同行评议者

Robert Taylor, MBChB, MRCP(UK), MRCP(London), DipMedTox, DipTher PGDME, FHEA FRCEM

Acute Hospital Sub Dean (Cornwall)

Honorary Clinical Senior Lecturer

Consultant Emergency Physician

University of Exeter Medical School

Royal Cornwall Hospitals NHS trust

Truro

UK

利益声明

RT declares that he has no competing interests.

编辑

Emma Quigley,

Section Editor, BMJ Best Practice

利益声明

EQ declares that she has no competing interests.

Tannaz Aliabadi-Oglesby,

Lead Section Editor, BMJ Best Practice

利益声明

TAO declares that she has no competing interests.

Julie Costello,

Comorbidities Editor, BMJ Best Practice

利益声明

JC declares that she has no competing interests.

Adam Mitchell,

Drug Editor, BMJ Best Practice

利益声明

AM declares that he has no competing interests.

内容使用需遵循免责声明